iLABMED Open Access Editor-in-Chief: Hongzhou Lu
Home iLABMED All Issues Volume 2 Issue 3
Volume 2 Issue 3, September 2024
PP. 141-226
|
9 articles
Original Article | Open Access
Accuracy evaluation of Roche Accu‐Chek Performa blood glucose meters at low glucose concentrations: A nine‐year retrospective study
Published: 17 June 2024
2024, 2(3): 141-148
Original Article | Open Access
Clinical efficacy and computed tomography diagnostic value of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis
Published: 27 August 2024
2024, 2(3): 149-156
Original Article | Open Access
A predictive model for ischemic colitis: Integrating clinical and laboratory parameters
Published: 14 July 2024
2024, 2(3): 157-167
Original Article | Open Access
A retrospective analysis of the relationship between dermatomyositis‐associated interstitial lung disease and disease duration, age, arterial blood gas pH, and serum Cl levels
Published: 12 September 2024
2024, 2(3): 168-177
Original Article | Open Access
Ginkgo biloba active compounds can modulate the development of acute mountain sickness and ischemic stroke as discovered by network pharmacology and molecular docking
Published: 03 September 2024
2024, 2(3): 178-196
Original Article | Open Access
Etiology, clinical features, and epidemiological analysis of diarrhea patients visiting a gastrointestinal clinic in a comprehensive hospital in Beijing, China, in 2023
Published: 19 September 2024
2024, 2(3): 197-204
Review | Open Access
Regulatory factors of ILC2 are therapeutic targets for lung inflammation
Published: 23 September 2024
2024, 2(3): 205-220
Case Report | Open Access
A case of central nervous system infection with Scedosporium boydii
Published: 11 June 2024
2024, 2(3): 221-225
Correction
Correction to “The exploration of cell population data in clinical use: Beyond infectious diseases”
Published: 16 July 2024
2024, 2(3): 226